We're hiring a Docket Specialist!
Join us in driving innovation at #CUAnschutz. Help manage cutting-edge IP from discovery to commercialization. Hybrid, great benefits & a mission that matters.
Open-rank (Senior to Principal)
https://t.co/O68eL7wzWq
#cucareers#hiring
We’re proud to have our own @GaliBaler, Ph.D. repping @CUInnovations on a powerhouse panel hosted by @Innosphere_V this Thurs, June 5!
Also Featuring:
🔹 Dan LaBarbera – Onconaut
🔹 Kelly Brough – Fitzsimons Innovation Community
Register now!
https://t.co/SO8xUDxPYB
We had an amazing time at #AUTM2025, networking, learning and sharing insights with the incredible innovation community! Thanks to everyone who connected with us and contributed to the vibrant discussions! 🚀
https://t.co/064K0rYwNh
#CUAnschutz#TechTransfer
Big congratulations to our incredible Senior Fellow Lily Elizabeth Feldman on her thesis publication. We are all so happy for you, Lily! #cuinnovations#cuanschutz
https://t.co/khisYgN1LV
Season's greetings from the team at CU innovations! Wishing you a joyous holiday season and a prosperous New Year. We look forward to the opportunities and achievements 2025 will bring.
#cuinnovations#cuanschutz
CUI's Executive Director Kimberly Muller had the honor of welcoming U.S. Army Lt. Gen. Telita Crosland,
@DHADirector, to the @CUAnschutz
campus earlier this month. Check out the newsroom to learn more about her visit!
https://t.co/XQxbwCa6Gw
We are thrilled to welcome @KellyBroughDen as the new CEO of @FIC_Colorado ! Please join us in celebrating this exciting new chapter of growth and innovation 🚀
https://t.co/jANAEgwA63
CU Anschutz Hematology Shines at ASH 2024!
@CUAnschutz made a huge impact at the 66th Annual American Society of Hematology Conference with a record-setting 47 abstracts.
Congratulations to the entire team for their dedication and hard work! https://t.co/3J8qIV31PY
Congratulations to Steve VanNurden, Associate Vice Chancellor for Biotechnology at @CUAnschutz , on his well-deserved retirement. Thank you, Steve, for your incredible contributions!
#cuinnovations#cuanschutz
https://t.co/8Q5os8pwZg
We are excited to share that @CUAnschutz has been awarded up to $46M in federal funding from ARPA-H! CU Innovations is thrilled to be part of this journey and learn more about how this funding could change the future of vision restoration.
#cuinnovations#cuanschutz
BREAKING: We are thrilled to announce that a research team led by #CUAnschutz will receive up to $46M in federal funding from @ARPAHealth to advance pioneering eye transplantation research aimed at curing blindness: https://t.co/HJmEkx5K0D
We’re filled with gratitude for our incredible partners, whose dedication drives innovation and transforms lives. Thank you for inspiring us every day—together, we’re making a meaningful impact on the future of healthcare.
#cuinnovations#cuanschutz
Big news from our partners at OncoVerity! They successfully obtained extended Series A funding to further develop cusatuzumab, a groundbreaking therapy for AML, with a Phase 2 trial underway. Visit our newsroom to learn more: https://t.co/3J8qIV3zFw
#cuinnovations#cuanschutz
🎉 Congratulations to Steven VanNurden on receiving the Lifetime Achievement Award at @cobioscience’s 21st Annual Awards Celebration presented by AGC Biologics! His dedication to building a thriving ecosystem for innovation has left a lasting mark on the community.
Congratulations to CU Healthcare Innovation Fund portfolio company, Jupiter Bioventures, who secured $70M in financing to fuel their mission of building therapeutics companies dedicated to transforming patient care! Read more in our newsroom: https://t.co/3J8qIV31PY
Now at @FIC_Colorado, RefinedScience’s growth highlights the power of collaboration between academia and industry. Visit our newsroom to learn more: https://t.co/3J8qIV3zFw
#cuinnovations#cuanschutz
Boost your research impact with clear communication! 🌟 Register now for a workshop on Wednesday 11/20 from 12–1 and learn how plain language can improve health literacy, build trust, and reach diverse populations:
#cuinnovations#cuanschutz
https://t.co/3j37G1EiIh
Congrats to Dr. Holers, Professor of Rheumatology at @CUAnschutz and Director of Faculty Ventures at CU Innovations, on receiving the 2024 Presidential Gold Medal from the @ACRheum! This prestigious award celebrates a lifetime of remarkable contributions to rheumatology.
#ACR24
Huge congratulations to Kristi Kuhn, MD, PhD, Professor and Head of Rheumatology at @CUAnschutz!
And there's more—another remarkable faculty member received a 2024 ACR award. Can you guess who it is? Stay tuned for the reveal!
#cuinnovations#cuanschutz#ACR24